Navigation Links
AIT Laboratories Expands Pharma Services
Date:9/22/2008

Names Industry Veteran as Executive Director

INDIANAPOLIS, Sept. 22 /PRNewswire/ -- AIT Laboratories, a leading forensics, pain management, clinical, and pharmaceutical testing facility, is announcing the expansion of its pharmaceutical services and has chosen an industry veteran to lead the division. AIT has named Ronald Shoup, former co-founder and chief scientific officer of West Lafayette-based Bioanalytical Systems, Inc. (Nasdaq: BASI), as its executive director of Pharma Services. "Ron brings 30 years of leadership, entrepreneurship, and scientific expertise to AIT as we look to expand our facility to meet the growing needs of the Pharma industry," said AIT President and CEO Michael A. Evans, Ph.D.

AIT supports clinical trials through its current drug analysis services and expects to offer regulated bioanalytical services for preclinical development in the future. Almost 20 years of experience in sample management enables AIT to offer the highest quality of organization for the collection, distribution, maintenance, and reconciliation of samples from clinical studies. As a premier leader in the application of mass spectrometry for biological samples, AIT routinely develops, validates, and performs mass spectrometry analysis in support of new drug development.

"My experience in analytical chemistry, regulatory audits, and the Pharma/biotech industry has given me challenging opportunities to solve scientific problems in drug development," said Shoup. "I know that my skills can help AIT to further enhance its success and reputation in the industry."

As pharmaceutical companies are going more towards their core business of making drugs, AIT is filling a need of providing superior bioanalytical testing in support of clinical trials. "Pharmaceutical companies are demanding high-quality, bioanalytical testing, analyses of biological samples, regulatory compliance, a commitment to quality assurance, robust methods development, and state-of-the-art technology," said AIT Chief Scientific Officer Andrea Terrell, Ph.D. "AIT provides all of these services to our clients."

AIT is a company that boasts an impressive collection of more than 100 bioanalytical assay methods, which identify over 300 drugs using some of the most advanced instrumentation in the industry. Through the innovations of its dedicated staff and scientists using multiple mass spectrometers and tandem mass spectrometer detectors coupled with GC, HPLC, and UPLC chromatography systems, AIT has seen phenomenal growth in its current markets over the past several years and is now using that success to further pursue the pharmaceutical industry. "I loved the growth story at AIT, and it was obvious to me that the company's culture and flexibility has allowed it to respond to its fast-growing markets," said Shoup.

About AIT Laboratories:

AIT Laboratories, headquartered in Indianapolis, Ind., is an independent reference laboratory that is a premiere testing and research institution recognized nationwide for superior customer service and quality in testing. In 2008, AIT was named one of the "Best Places to Work in Indiana" by the Indiana Chamber of Commerce. In 2007 and 2008, AIT was recognized by Inc. magazine as one of the top 5,000 fastest-growing, private companies in the nation. Learn more about AIT Laboratories at http://www.aitlabs.com .

Contact: Raquel Bahamonde

Executive Director of Corporate Communications, AIT Laboratories

Phone: (317) 243-3894, ext. 476

Cell: (317) 308-0064

E-mail: rbahamonde@aitlabs.com Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Andrea Terrell https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=72455 Michael Evans https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=72454


'/>"/>
SOURCE AIT Laboratories
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Codexis Appoints Singapore Laboratories Managing Director
2. ARUP Laboratories and Premier Extend Contract for Reference Laboratory Testing Services
3. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
4. Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration
5. Stiefel Laboratories Appoints Two New Members to Board of Directors
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Methimazole Tablets USP, 5 mg and 10 mg
7. ARUP Laboratories Releases ARUP Consult(R) 2.0
8. Forest Laboratories Lexapro and Generics-Dominated Fluoxetine Lead First-Line Therapy in the Treatment for Major Depression
9. Carrington Laboratories Common Stock Now Trading on the OTC Bulletin Board: CARN.OB
10. Free White Paper Helps Biotech Laboratories Maintain a High Level of Infection Control
11. Romark Laboratories Names Emmet B. Keeffe, M.D. Vice President and Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the ... Convention Center and will showcase its product’s latest features from June 26 to ... a scientific poster on Disrupting Clinical Trials in The Cloud during the conference. ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity ... intelligent tools designed, tuned and optimized exclusively for Okuma CNC machining centers at ... result of a collaboration among several companies with expertise in toolholding, cutting tools, ...
(Date:6/23/2016)... India , June 23, 2016 ... media market research report to its pharmaceuticals section ... profiles, product details and much more. ... spread across 151 pages, profiling 15 companies and ... available at http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . ...
(Date:6/22/2016)... , June 22, 2016 Research and ... Global Markets" report to their offering. ... billion in 2014 from $29.3 billion in 2013. The market is ... of 13.8% from 2015 to 2020, increasing from $50.6 billion in ... projected product forecasts during the forecast period (2015 to 2020) are ...
Breaking Biology Technology:
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting ... are setting a new clinical standard in telehealth thanks ... By leveraging the higi platform, IMPOWER patients can routinely ... pulse and body mass index, and, when they opt ... and convenient visit to a local retail location at ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys has ... CEO, Barrett Bready , M.D., who returned to ... the original technical leadership team, including Chief Technology Officer, ... Product Development, Steve Nurnberg and Vice President of Software ... the company. Dr. Bready served as CEO ...
(Date:3/23/2016)... WAKEFIELD, Massachusetts , March 23, 2016 ... kombiniert im Interesse erhöhter Sicherheit Gesichts- und ... Xura, Inc. (NASDAQ: MESG ... heute bekannt, dass das Unternehmen mit SpeechPro ... insbesondere aus der Finanzdienstleistungsbranche, wird die Möglichkeit ...
Breaking Biology News(10 mins):